The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neglected Tropical Diseases Diagnosis Market Research Report 2025
Synopsis
Neglected Tropical Diseases Diagnosis is the procedure to test if the patient have the Neglected Tropical.
The global Neglected Tropical Diseases Diagnosis market was valued at US$ 6267.3 million in 2023 and is anticipated to reach US$ 8008.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis.
Report Scope
The Neglected Tropical Diseases Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Segment by Type
Conventional Method
Molecular/Modern Method
Segment by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neglected Tropical Diseases Diagnosis is the procedure to test if the patient have the Neglected Tropical.
The global Neglected Tropical Diseases Diagnosis market was valued at US$ 6267.3 million in 2023 and is anticipated to reach US$ 8008.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis.
Report Scope
The Neglected Tropical Diseases Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Segment by Type
Conventional Method
Molecular/Modern Method
Segment by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Conventional Method
1.2.3 Molecular/Modern Method
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Labs
1.3.3 Hospitals /Clinics
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Diagnosis Market Perspective (2019-2030)
2.2 Neglected Tropical Diseases Diagnosis Growth Trends by Region
2.2.1 Global Neglected Tropical Diseases Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neglected Tropical Diseases Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Neglected Tropical Diseases Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Neglected Tropical Diseases Diagnosis Market Dynamics
2.3.1 Neglected Tropical Diseases Diagnosis Industry Trends
2.3.2 Neglected Tropical Diseases Diagnosis Market Drivers
2.3.3 Neglected Tropical Diseases Diagnosis Market Challenges
2.3.4 Neglected Tropical Diseases Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Diagnosis Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Neglected Tropical Diseases Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Diagnosis Revenue
3.4 Global Neglected Tropical Diseases Diagnosis Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Diagnosis Revenue in 2023
3.5 Neglected Tropical Diseases Diagnosis Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Diagnosis Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Diagnosis Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Type (2025-2030)
5 Neglected Tropical Diseases Diagnosis Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
6.2 North America Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
6.4 North America Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
7.2 Europe Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
7.4 Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
9.2 Latin America Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Introduction
11.1.4 Abbott Laboratories Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter/Danaher
11.2.1 Beckman Coulter/Danaher Company Detail
11.2.2 Beckman Coulter/Danaher Business Overview
11.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Introduction
11.2.4 Beckman Coulter/Danaher Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.2.5 Beckman Coulter/Danaher Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Detail
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Life Technology
11.4.1 Life Technology Company Detail
11.4.2 Life Technology Business Overview
11.4.3 Life Technology Neglected Tropical Diseases Diagnosis Introduction
11.4.4 Life Technology Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.4.5 Life Technology Recent Development
11.5 Novartis Diagnostics., Ltd.
11.5.1 Novartis Diagnostics., Ltd. Company Detail
11.5.2 Novartis Diagnostics., Ltd. Business Overview
11.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Introduction
11.5.4 Novartis Diagnostics., Ltd. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.5.5 Novartis Diagnostics., Ltd. Recent Development
11.6 Ortho-Clinical Diagnostics
11.6.1 Ortho-Clinical Diagnostics Company Detail
11.6.2 Ortho-Clinical Diagnostics Business Overview
11.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Introduction
11.6.4 Ortho-Clinical Diagnostics Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.6.5 Ortho-Clinical Diagnostics Recent Development
11.7 Premier Medical Corporation Ltd.
11.7.1 Premier Medical Corporation Ltd. Company Detail
11.7.2 Premier Medical Corporation Ltd. Business Overview
11.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Introduction
11.7.4 Premier Medical Corporation Ltd. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.7.5 Premier Medical Corporation Ltd. Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Detail
11.8.2 Siemens Healthcare Business Overview
11.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Introduction
11.8.4 Siemens Healthcare Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.8.5 Siemens Healthcare Recent Development
11.9 Wako Chemicals, Inc.
11.9.1 Wako Chemicals, Inc. Company Detail
11.9.2 Wako Chemicals, Inc. Business Overview
11.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Introduction
11.9.4 Wako Chemicals, Inc. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024)
11.9.5 Wako Chemicals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Conventional Method
Table 3. Key Players of Molecular/Modern Method
Table 4. Global Neglected Tropical Diseases Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Neglected Tropical Diseases Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Neglected Tropical Diseases Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Neglected Tropical Diseases Diagnosis Market Share by Region (2019-2024)
Table 8. Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Neglected Tropical Diseases Diagnosis Market Share by Region (2025-2030)
Table 10. Neglected Tropical Diseases Diagnosis Market Trends
Table 11. Neglected Tropical Diseases Diagnosis Market Drivers
Table 12. Neglected Tropical Diseases Diagnosis Market Challenges
Table 13. Neglected Tropical Diseases Diagnosis Market Restraints
Table 14. Global Neglected Tropical Diseases Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Neglected Tropical Diseases Diagnosis Market Share by Players (2019-2024)
Table 16. Global Top Neglected Tropical Diseases Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Diagnosis as of 2023)
Table 17. Ranking of Global Top Neglected Tropical Diseases Diagnosis Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Neglected Tropical Diseases Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neglected Tropical Diseases Diagnosis Product Solution and Service
Table 21. Date of Enter into Neglected Tropical Diseases Diagnosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neglected Tropical Diseases Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Type (2019-2024)
Table 25. Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Type (2025-2030)
Table 27. Global Neglected Tropical Diseases Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Application (2019-2024)
Table 29. Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Application (2025-2030)
Table 31. North America Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Neglected Tropical Diseases Diagnosis Product
Table 49. Abbott Laboratories Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Beckman Coulter/Danaher Company Detail
Table 52. Beckman Coulter/Danaher Business Overview
Table 53. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product
Table 54. Beckman Coulter/Danaher Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 55. Beckman Coulter/Danaher Recent Development
Table 56. Bio-Rad Laboratories, Inc. Company Detail
Table 57. Bio-Rad Laboratories, Inc. Business Overview
Table 58. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product
Table 59. Bio-Rad Laboratories, Inc. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 60. Bio-Rad Laboratories, Inc. Recent Development
Table 61. Life Technology Company Detail
Table 62. Life Technology Business Overview
Table 63. Life Technology Neglected Tropical Diseases Diagnosis Product
Table 64. Life Technology Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 65. Life Technology Recent Development
Table 66. Novartis Diagnostics., Ltd. Company Detail
Table 67. Novartis Diagnostics., Ltd. Business Overview
Table 68. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product
Table 69. Novartis Diagnostics., Ltd. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 70. Novartis Diagnostics., Ltd. Recent Development
Table 71. Ortho-Clinical Diagnostics Company Detail
Table 72. Ortho-Clinical Diagnostics Business Overview
Table 73. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product
Table 74. Ortho-Clinical Diagnostics Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 75. Ortho-Clinical Diagnostics Recent Development
Table 76. Premier Medical Corporation Ltd. Company Detail
Table 77. Premier Medical Corporation Ltd. Business Overview
Table 78. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product
Table 79. Premier Medical Corporation Ltd. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 80. Premier Medical Corporation Ltd. Recent Development
Table 81. Siemens Healthcare Company Detail
Table 82. Siemens Healthcare Business Overview
Table 83. Siemens Healthcare Neglected Tropical Diseases Diagnosis Product
Table 84. Siemens Healthcare Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 85. Siemens Healthcare Recent Development
Table 86. Wako Chemicals, Inc. Company Detail
Table 87. Wako Chemicals, Inc. Business Overview
Table 88. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product
Table 89. Wako Chemicals, Inc. Revenue in Neglected Tropical Diseases Diagnosis Business (2019-2024) & (US$ Million)
Table 90. Wako Chemicals, Inc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Neglected Tropical Diseases Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. Conventional Method Features
Figure 4. Molecular/Modern Method Features
Figure 5. Global Neglected Tropical Diseases Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Neglected Tropical Diseases Diagnosis Market Share by Application: 2023 VS 2030
Figure 7. Clinical Labs Case Studies
Figure 8. Hospitals /Clinics Case Studies
Figure 9. Home Healthcare Case Studies
Figure 10. Neglected Tropical Diseases Diagnosis Report Years Considered
Figure 11. Global Neglected Tropical Diseases Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Neglected Tropical Diseases Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Neglected Tropical Diseases Diagnosis Market Share by Region: 2023 VS 2030
Figure 14. Global Neglected Tropical Diseases Diagnosis Market Share by Players in 2023
Figure 15. Global Top Neglected Tropical Diseases Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Diagnosis as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Diagnosis Revenue in 2023
Figure 17. North America Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Neglected Tropical Diseases Diagnosis Market Share by Country (2019-2030)
Figure 19. United States Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Neglected Tropical Diseases Diagnosis Market Share by Country (2019-2030)
Figure 23. Germany Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Neglected Tropical Diseases Diagnosis Market Share by Region (2019-2030)
Figure 31. China Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Neglected Tropical Diseases Diagnosis Market Share by Country (2019-2030)
Figure 39. Mexico Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Share by Country (2019-2030)
Figure 43. Turkey Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Neglected Tropical Diseases Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 46. Beckman Coulter/Danaher Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 47. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 48. Life Technology Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 49. Novartis Diagnostics., Ltd. Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 50. Ortho-Clinical Diagnostics Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 51. Premier Medical Corporation Ltd. Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 52. Siemens Healthcare Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 53. Wako Chemicals, Inc. Revenue Growth Rate in Neglected Tropical Diseases Diagnosis Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
